Selventa is a biomarker discovery company that enables personalized healthcare
Recent News:
Upcoming Events:
May 19-22, 2012
May 22-24, 2012
case study:
Competitive Differentiation
Selventa built and compared data-driven signaling networks in response to multiple drugs, both qualitatively and quantitatively.
Download PDFMolecular Mechanisms for Adverse Events
Selventa identified subtle molecular injury mechanisms in pre-clinical animal models that can be used to develop a predictive safety assay.
Download PDFStrategic Partnership
Selventa maximized the use of patient data to quickly identify mechanisms for a specific patient population in a given disease to better guide a trial design.
Download PDFResponse Biomarker
Selventa developed a verified, generalized methodology for companion biomarker development in the absence of available clinical outcomes data.
Download PDFIdentification of Disease Mechanism
Selventa’s disease modeling approach can be used to evaluate appropriate mono- or combination-therapy options at the level of individual patients
Download PDFBEL portal:
Please visit the BEL Portal